2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol
C22H25F2N5O3 — CID 155450804
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol
2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol (PubChem CID 155450804) has the molecular formula C22H25F2N5O3 and a molecular weight of 445.47 g/mol. Its IUPAC name is 2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol.
Molecular Properties
| Compound Name | 2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol |
|---|---|
| PubChem CID | 155450804 |
| Molecular Formula | C22H25F2N5O3 |
| Molecular Weight | 445.47 g/mol |
| Exact Mass | 445.19 |
| IUPAC Name | 2-[4-[[4-[3-(difluoromethyl)-1-(oxan-4-yl)pyrazol-5-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol |
| SMILES | CC(C)(O)c1cc(Nc2cc(Oc3cc(C(F)F)nn3C3CCOCC3)ccn2)ccn1 |
| InChI | InChI=1S/C22H25F2N5O3/c1-22(2,30)18-11-14(3-7-25-18)27-19-12-16(4-8-26-19)32-20-13-17(21(23)24)28-29(20)15-5-9-31-10-6-15/h3-4,7-8,11-13,15,21,30H,5-6,9-10H2,1-2H3,(H,25,26,27) |
| InChIKey | KRWSZYNFQCXJIP-UHFFFAOYSA-N |
| XLogP | 4.73 |
| TPSA | 94.32 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.47 |
| LogP ≤ 5 | 4.73 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155450804 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.